{
    "nctId": "NCT00869804",
    "briefTitle": "Heading Off Peripheral Neuropathy With Exercise",
    "officialTitle": "Pilot Randomized Study of Aerobic and Resistance Exercise for Women Undergoing Treatment for Breast Cancer With Taxanes.",
    "overallStatus": "TERMINATED",
    "conditions": "Peripheral Nervous System Disorders, Breast Neoplasms, Chemotherapy",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 19,
    "primaryOutcomeMeasure": "effect size for reduction of neuropathic symptoms",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* age 19 or older with newly diagnosed Stage I-IIIa invasive breast cancer who are to be treated with a taxane-based chemotherapy regimen (with paclitaxel or docetaxel) and thus are at risk for the development of CIPN.\n\nExclusion Criteria:\n\n* any disease (e.g. diabetes, HIV) that results in peripheral neuropathy;\n* any disease or disorder that results in muscle weakness (such as chronic fatigue syndrome, multiple sclerosis, spinal cord tumors or injuries, stroke, preexisting cardiopulmonary disease);\n* any disease or disorder that would preclude strength training exercises (such as bone metastasis, osteoporosis);\n* individuals with diagnosed lymphedema or advanced disease (\\> Stage IIIa, or metastatic disease) at high risk for bone metastases and pathologic fracture will be excluded.",
    "sex": "ALL",
    "minimumAge": "19 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}